Fact checked byGina Brockenbrough, MA

Read more

August 12, 2022
1 min read
Save

KidneyX announces new artificial kidney prize with $10.5 million in funding

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

HHS and the American Society of Nephrology launched a new KidneyX prize that began accepting submissions on Aug. 11, 2022.

According to a press release, the second phase of the Artificial Kidney Prize includes two tracts. Track one is called “Accelerating the Prototype of a Bioartificial Kidney,” and innovators are welcome to submit development plans for a prototype bioartificial kidney. Track two is called “Components and Tools that Enable the Development of an Artificial Kidney,” and innovators can submit proposals for tools or components that adapt regenerative medicine, cellular engineering, tissue engineering, systems biology and/or synthetic biology methods to solve an obstacle currently faced in the development of a fully functional artificial kidney.

Infographic showing KidneyX prize
A total of $10.5 million in funding will be split between nine prize winners. Data were derived from the press release.

Past KidneyX prize winners are eligible to enter the second phase of the competition. Track one submissions will close Oct. 28, 2022, and track two submissions will close Jan. 28, 2023.

A total of $10.5 million in funding will be split between nine prize winners, consisting of up to three winners from track one and up to six winners from track two. Track one winners will receive $1.5 million and Track two winners will receive $1 million.

“We are hopeful that KidneyX Phase 2’s focus on the integration and advancement of artificial kidney prototypes will result in breakthroughs that ensure a healthier future while reducing health disparities,” the Assistant Secretary for Health for the HHS Admiral Rachel L. Levine, MD, said in the release.